Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib

BACKGROUND: Previous studies have reported that epidermal growth factor receptor (EGFR) mutation in tumor tissue and peripheral blood can predict the response to EGFR tyrosine kinase inhibitor (TKI) in non-small cell lung cancer (NSCLC). However, the heterogeneity of the sample sources makes it diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Fei, Wu, Jingxun, Xue, Cong, Zhao, Yuanyuan, Jiang, Wei, Lin, Liping, Wu, Xuan, Lu, Yachao, Bai, Hua, Xu, Jiasen, Zhu, Guanshan, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525047/
https://www.ncbi.nlm.nih.gov/pubmed/23251095
http://dx.doi.org/10.2147/OTT.S37289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525047/
https://www.ncbi.nlm.nih.gov/pubmed/23251095
http://dx.doi.org/10.2147/OTT.S37289

Ejemplares similares